Evidence map›Paper›PMID 36284707›Full record

ReviewComputational and structural biotechnology journal2022

The orchestrated signaling by PI3Kα and PTEN at the membrane interface.

Danai Maria Kotzampasi, Kyriaki Premeti, Alexandra Papafotika, Vasiliki Syropoulou, Savvas Christoforidis, Zoe Cournia, George Leondaritis

Open access · goldAbstract readReview
In one paragraph

Review in Computational and structural biotechnology journal, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Free energy landscape of the PI3Kα C-terminal activation.Computational and structural biotechnology journal · 2024
    Article
  6. Review
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Danai Maria KotzampasiBiomedical Research Foundation, Academy of Athens, Athens 11527, Greece.
Kyriaki PremetiLaboratory of Pharmacology, Faculty of Medicine, University of Ioannina, Ioannina 45110, Greece.
Alexandra PapafotikaLaboratory of Biological Chemistry, Faculty of Medicine, School of Health Sciences, University of Ioannina, Ioannina 45110, Greece.
Vasiliki SyropoulouLaboratory of Pharmacology, Faculty of Medicine, University of Ioannina, Ioannina 45110, Greece.
Savvas ChristoforidisLaboratory of Biological Chemistry, Faculty of Medicine, School of Health Sciences, University of Ioannina, Ioannina 45110, Greece.
Zoe CourniaBiomedical Research Foundation, Academy of Athens, Athens 11527, Greece.
George LeondaritisLaboratory of Pharmacology, Faculty of Medicine, University of Ioannina, Ioannina 45110, Greece.
University of Ioannina · GRAcademy of Athens · GRUniversity of Crete · GR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The oncogene PI3Kα and the tumor suppressor PTEN represent two antagonistic enzymatic activities that regulate the interconversion of the phosphoinositide lipids PI(4,5)P

Indexed as

AllosteryMembrane-bindingMembrane traffickingPhosphoinositidesPI3KαPTEN

Identifiers

PMID36284707
PMCPMC9578963
OpenAlexW4303183520

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.